VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,911,908 | -6.5% | 521,260 | +32.2% | 0.08% | -8.0% |
| Q2 2023 | $7,395,394 | +32.7% | 394,421 | +2.1% | 0.09% | +15.8% |
| Q1 2023 | $5,572,840 | -23.5% | 386,466 | +2.7% | 0.08% | -21.6% |
| Q4 2022 | $7,280,960 | -43.5% | 376,277 | +0.3% | 0.10% | -46.1% |
| Q3 2022 | $12,881,000 | +462.0% | 374,995 | +150.0% | 0.18% | +414.3% |
| Q2 2022 | $2,292,000 | -33.0% | 150,000 | 0.0% | 0.04% | -37.5% |
| Q1 2022 | $3,423,000 | -47.3% | 150,000 | -14.8% | 0.06% | -39.8% |
| Q4 2021 | $6,490,000 | -31.8% | 176,027 | -13.1% | 0.09% | -40.0% |
| Q3 2021 | $9,518,000 | -23.7% | 202,500 | -2.1% | 0.16% | -33.2% |
| Q2 2021 | $12,467,000 | – | 206,921 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
| Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
| Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
| MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
| Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
| ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
| Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
| Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
| Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
| Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |